Javascript must be enabled to continue!
IgA Vasculitis and IgA Nephropathy: Same Disease?
View through CrossRef
Many authors suggested that IgA Vasculitis (IgAV) and IgA Nephropathy (IgAN) would be two clinical manifestations of the same disease; in particular, that IgAV would be the systemic form of the IgAN. A limited number of studies have included sufficient children or adults with IgAN or IgAV (with or without nephropathy) and followed long enough to conclude on differences or similarities in terms of clinical, biological or histological presentation, physiopathology, genetics or prognosis. All therapeutic trials available on IgAN excluded patients with vasculitis. IgAV and IgAN could represent different extremities of a continuous spectrum of the same disease. Due to skin rash, patients with IgAV are diagnosed precociously. Conversely, because of the absence of any clinical signs, a renal biopsy is practiced for patients with an IgAN to confirm nephropathy at any time of the evolution of the disease, which could explain the frequent chronic lesions at diagnosis. Nevertheless, the question that remains unsolved is why do patients with IgAN not have skin lesions and some patients with IgAV not have nephropathy? Larger clinical studies are needed, including both diseases, with a common histological classification, and stratified on age and genetic background to assess renal prognosis and therapeutic strategies.
Title: IgA Vasculitis and IgA Nephropathy: Same Disease?
Description:
Many authors suggested that IgA Vasculitis (IgAV) and IgA Nephropathy (IgAN) would be two clinical manifestations of the same disease; in particular, that IgAV would be the systemic form of the IgAN.
A limited number of studies have included sufficient children or adults with IgAN or IgAV (with or without nephropathy) and followed long enough to conclude on differences or similarities in terms of clinical, biological or histological presentation, physiopathology, genetics or prognosis.
All therapeutic trials available on IgAN excluded patients with vasculitis.
IgAV and IgAN could represent different extremities of a continuous spectrum of the same disease.
Due to skin rash, patients with IgAV are diagnosed precociously.
Conversely, because of the absence of any clinical signs, a renal biopsy is practiced for patients with an IgAN to confirm nephropathy at any time of the evolution of the disease, which could explain the frequent chronic lesions at diagnosis.
Nevertheless, the question that remains unsolved is why do patients with IgAN not have skin lesions and some patients with IgAV not have nephropathy? Larger clinical studies are needed, including both diseases, with a common histological classification, and stratified on age and genetic background to assess renal prognosis and therapeutic strategies.
Related Results
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
AbstractBecause abnormalities of mucosal immunity have been suggested in human IgA nephropathy, we examined the involvement of mucosal immunity in IgA deposition to the kidney in h...
Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Abstract
Chemical and functional properties of IgA binding factor(s) (IgA-BF) from both murine Con A-activated spleen cells and Fc gamma R+, Fc alpha R+ T hybridoma ...
Etiology of IgA nephropathy syndrome
Etiology of IgA nephropathy syndrome
Since Berger's original paper on mesangial IgA‐IgG deposition with hematuria, there have been a number of clinical and pathological studies regarding IgA immune complexes, the mech...
An update on the nomenclature for cutaneous vasculitis
An update on the nomenclature for cutaneous vasculitis
Purpose of review
Cutaneous vasculitis reflects a spectrum ranging from skin limited to severe systemic forms. To date, there is still no generally acknowledged nomencl...
An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti‐IgA) and IgA deficiency
An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti‐IgA) and IgA deficiency
BACKGROUND: Immunoglobulin A antibodies (anti‐IgA) are rare but can cause transfusion‐associated anaphylaxis. The detection of anti‐IgA has traditionally been performed using a lab...
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
ABSTRACTObjectives:The aim was to investigate age‐dependent serum levels and occurrence of elevated celiac disease (CD)–related antibodies in young children, to define the optimal ...
Resistance of Normal Serum IgA and Secretory IgA to Bacterial IgA Proteases: Evidence for the Presence of Enzyme‐Neutralizing Antibodies in Both Serum and Secretory IgA, and Also in Serum IgG
Resistance of Normal Serum IgA and Secretory IgA to Bacterial IgA Proteases: Evidence for the Presence of Enzyme‐Neutralizing Antibodies in Both Serum and Secretory IgA, and Also in Serum IgG
AbstractNormal serum IgA and secretory IgA (sIgA) of subclass IgA1 were isolated from pooled human serum and milk, respectively. They were tested for their susceptibility to bacter...
Effects of serial plasmapheresis on serum IgA levels in IgA‐deficient blood donors with IgA‐suppressor T cells
Effects of serial plasmapheresis on serum IgA levels in IgA‐deficient blood donors with IgA‐suppressor T cells
Seventeen IgA‐deficient blood donors, without antibodies to IgA, underwent plasmapheresis four to eight consecutive times at intervals of 8 weeks or less to provide fresh‐frozen pl...

